Stay updated on Nivolumab for Uterine Cancer - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.

Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications section now states entries are automatically filled from PubMed and may not all be about the study. The page revision is updated to v3.3.2, and the previous PubMed description and v3.2.0 revision have been removed.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the site-wide notice about government funding and NIH operations; core study details and links remain unchanged.SummaryDifference0.4%

- Check42 days agoChange DetectedNo additions or deletions were detected between the two screenshots. The page content remains unchanged.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check78 days agoChange DetectedUpdated medical term from Endometrioid stromal sarcoma to Endometrial stromal sarcoma and bumped revision from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision: v3.0.2 added and the 'Back to Top' option removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.